274 related articles for article (PubMed ID: 33607473)
1. Chronic Systemic Inflammatory Skin Disease as a Risk Factor for Cardiovascular Disease.
Bulger DA; Minhas S; Asbeutah AA; Kayali S; Shirwany HAK; Patel JR; Seitz MP; Clark K; Patel T; Khouzam RN
Curr Probl Cardiol; 2021 May; 46(5):100799. PubMed ID: 33607473
[TBL] [Abstract][Full Text] [Related]
2. A fragment of type VI collagen alpha-6 chain is elevated in serum from patients with atopic dermatitis, psoriasis, hidradenitis suppurativa, systemic lupus erythematosus and melanoma.
Holm Nielsen S; Port H; Møller Hausgaard C; Holm JG; Thyssen JP; Groen SS; Karsdal M; Nielsen VW; Egeberg A; Bay-Jensen AC; Thomsen SF
Sci Rep; 2023 Feb; 13(1):3056. PubMed ID: 36810294
[TBL] [Abstract][Full Text] [Related]
3. Sex-Specific Cardiovascular Comorbidities with Associations in Dermatologic and Rheumatic Disorders.
Kerkhof PLM; Khamaganova I
Adv Exp Med Biol; 2018; 1065():489-509. PubMed ID: 30051403
[TBL] [Abstract][Full Text] [Related]
4. Co-morbidities in inflammatory dermatological diseases. Psoriasis, hidradenitis suppurativa, and cardiovascular risk factors.
Miller IM
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324088
[TBL] [Abstract][Full Text] [Related]
5. Association Between Inflammatory Skin Disease and Cardiovascular and Cerebrovascular Co-Morbidities in US Adults: Analysis of Nationwide Inpatient Sample Data.
Kwa MC; Silverberg JI
Am J Clin Dermatol; 2017 Dec; 18(6):813-823. PubMed ID: 28534318
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Disease-Associated Skin Conditions.
Hojman L; Karsulovic C
Vasc Health Risk Manag; 2022; 18():43-53. PubMed ID: 35210782
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and inflammatory skin conditions.
Steele CE; Morrell D; Evans M
Curr Opin Pediatr; 2019 Aug; 31(4):515-522. PubMed ID: 31169544
[TBL] [Abstract][Full Text] [Related]
8. Multimorbidity and mortality risk in hospitalized adults with chronic inflammatory skin disease in the United States.
Narla S; Silverberg JI
Arch Dermatol Res; 2020 Sep; 312(7):507-512. PubMed ID: 32047999
[TBL] [Abstract][Full Text] [Related]
9. Inflammation: A Contributor to Depressive Comorbidity in Inflammatory Skin Disease.
Farzanfar D; Dowlati Y; French LE; Lowes MA; Alavi A
Skin Pharmacol Physiol; 2018; 31(5):246-251. PubMed ID: 29953999
[TBL] [Abstract][Full Text] [Related]
10. A Review of Skin Disease in Schizophrenia.
McPhie ML; Bridgman AC; Kirchhof MG
Dermatology; 2021; 237(2):248-261. PubMed ID: 32759610
[TBL] [Abstract][Full Text] [Related]
11. Top Ten Research Priorities for Psoriasis, Atopic Dermatitis and Hidradenitis Suppurativa: The SkIN Canada Priority Setting Initiative.
Drucker AM; Kleiner O; Manion R; Philip A; Dutz J; Barnard K; Fradette J; Germain L; Gniadecki R; Litvinov I; Logsetty S; Manolson M; Mydlarski PR; Piguet V; Ward D; Zhou Y; Chan AW;
J Cutan Med Surg; 2023; 27(2):133-139. PubMed ID: 36995350
[TBL] [Abstract][Full Text] [Related]
12. A Molecular Perspective on the Potential Benefits of Metformin for the Treatment of Inflammatory Skin Disorders.
Chang JE; Choi MS
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255783
[TBL] [Abstract][Full Text] [Related]
13. A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa.
Fabrazzo M; Cipolla S; Signoriello S; Camerlengo A; Calabrese G; Giordano GM; Argenziano G; Galderisi S
Eur Psychiatry; 2021 Nov; 64(1):e71. PubMed ID: 34819201
[TBL] [Abstract][Full Text] [Related]
14. Hidradenitis suppurativa and associated diseases.
Pescitelli L; Ricceri F; Prignano F
G Ital Dermatol Venereol; 2018 Jun; 153(3 Suppl 2):8-17. PubMed ID: 30468375
[TBL] [Abstract][Full Text] [Related]
15. Genetics and the metabolic syndrome.
Fanning E; O'Shea D
Clin Dermatol; 2018; 36(1):9-13. PubMed ID: 29241759
[TBL] [Abstract][Full Text] [Related]
16. Lipid Alterations and Metabolism Disturbances in Selected Inflammatory Skin Diseases.
Nowowiejska J; Baran A; Flisiak I
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108216
[TBL] [Abstract][Full Text] [Related]
17. Off-label dermatologic uses of IL-17 inhibitors.
Wu KK; Dao H
J Dermatolog Treat; 2022 Feb; 33(1):41-47. PubMed ID: 32116066
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of risk in chronic cutaneous inflammatory conditions for malignant transformation.
Ju T; Hernandez L; Mohsin N; Labib A; Frech F; Nouri K
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):231-242. PubMed ID: 36251409
[TBL] [Abstract][Full Text] [Related]
19. Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches.
Tampouratzi E; Kanni T; Katsantonis J; Douvali T
F1000Res; 2019; 8():2002. PubMed ID: 33456757
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous manifestations of obesity and themetabolic syndrome.
Uzuncakmak TK; Akdeniz N; Karadag AS
Clin Dermatol; 2018; 36(1):81-88. PubMed ID: 29241757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
